Histone deacetylase 8 (HDAC8) and its inhibitors with selectivity to other isoforms: An overview

被引:88
|
作者
Banerjee, Suvankar [1 ]
Adhikari, Nilanjan [1 ,2 ]
Amin, Sk Abdul [1 ]
Jha, Tarun [1 ]
机构
[1] Jadavpur Univ, Dept Pharmaceut Technol, Nat Sci Lab, Div Med & Pharmaceut Chem, POB 17020, Kolkata 700032, W Bengal, India
[2] ADAMAS Univ, Sch Pharmaceut Technol, Barasat Barrackpore Rd,PO Jagannathpur, Kolkata 700126, W Bengal, India
关键词
Histone deacetylase; HDAC8; Cancer; inhibitor; Structure-activity relationship (SAR); Quantitative structure-activity relationship (QSAR); DE-LANGE-SYNDROME; SUBEROYLANILIDE HYDROXAMIC ACID; ZINC-BINDING GROUP; BIOLOGICAL EVALUATION; PHASE-I; MOLECULAR-MECHANISMS; CRYSTAL-STRUCTURE; ACTIVITY ASSAY; UP-REGULATION; DESIGN;
D O I
10.1016/j.ejmech.2018.12.039
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The histone deacetylases (HDACs) enzymes provided crucial role in transcriptional regulation of cells through deacetylation of nuclear histone proteins. Discoveries related to the HDAC8 enzyme activity signified the importance of HDAC8 isoform in cell proliferation, tumorigenesis, cancer, neuronal disorders, parasitic/viral infections and other epigenetic regulations. The pan-HDAC inhibitors can confront these conditions but have chances to affect epigenetic functions of other HDAC isoforms. Designing of selective HDAC8 inhibitors is a key feature to combat the pathophysiological and diseased conditions involving the HDAC8 activity. This review is concerned about the structural and positional aspects of HDAC8 in the HDAC family. It also covers the contributions of HDAC8 in the pathophysiological conditions, a preliminary discussion about the recent scenario of HDAC8 inhibitors. This review might help to deliver the structural, functional and computational information in order to identify and design potent and selective HDAC8 inhibitors for target specific treatment of diseases involving HDAC8 enzymatic activity. (C) 2018 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:214 / 240
页数:27
相关论文
共 50 条
  • [41] Diverse classes of HDAC8 inhibitors: in search of molecular fingerprints that regulate activity
    Amin, Sk Abdul
    Adhikari, Nilanjan
    Jha, Tarun
    FUTURE MEDICINAL CHEMISTRY, 2018, 10 (13) : 1589 - 1602
  • [42] Design, Synthesis, and Biological Evaluation of Tetrahydroisoquinoline-Based Histone Deacetylase 8 Selective Inhibitors
    Taha, Taha Y.
    Aboukhatwa, Shaimaa M.
    Knopp, Rachel C.
    Ikegaki, Naohiko
    Abdelkarim, Hazem
    Neerasa, Jayaprakash
    Lu, Yunlong
    Neelarapu, Raghupathi
    Hanigan, Thomas W.
    Thatcher, Gregory R. J.
    Petukhov, Pavel A.
    ACS MEDICINAL CHEMISTRY LETTERS, 2017, 8 (08): : 824 - 829
  • [43] MOLECULAR MODELING OF THE INTERACTIONS BETWEEN HISTONE DEACETYLASE 8 AND INHIBITORS
    Huang, Dawei
    Li, Xiaohui
    Xiu, Zhilong
    JOURNAL OF THEORETICAL & COMPUTATIONAL CHEMISTRY, 2012, 11 (04) : 907 - 924
  • [44] Identification of Novel Human HDAC8 Inhibitors by Pharmacophore-based Virtual Screening and Density Functional Theory Approaches
    Kim, Seokmin
    Lee, Yuno
    Kim, Songmi
    Lee, Sang Jik
    Heo, Phil Kyeong
    Kim, Siu
    Kwon, Yong Jung
    Lee, Keun Woo
    BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2018, 39 (02): : 197 - 206
  • [45] Isophthalic Acid-Based HDAC Inhibitors as Potent Inhibitors of HDAC8 from Schistosoma mansoni
    Stenzel, Katharina
    Chakrabarti, Alokta
    Melesina, Jelena
    Hansen, Finn K.
    Lancelot, Julien
    Herkenhohner, Simon
    Lungerich, Beate
    Marek, Martin
    Romier, Christophe
    Pierce, Raymond. J.
    Sippl, Wolfgang
    Jung, Manfred
    Kurz, Thomas
    ARCHIV DER PHARMAZIE, 2017, 350 (08)
  • [46] Hydroxamates of para-aminobenzoic acid as selective inhibitors of HDAC8
    Kulandaivelu, Umasankar
    Chilakamari, Laxmi Manasa
    Jadav, Surender Singh
    Rao, Tadikonda Rama
    Jayaveera, K. N.
    Shireesha, Boyapati
    Hauser, Alexander-Thomas
    Senger, Johanna
    Marek, Martin
    Romier, Christophe
    Jung, Manfred
    Jayaprakash, Venkatesan
    BIOORGANIC CHEMISTRY, 2014, 57 : 116 - 120
  • [47] HDAC8 substrates: Histones and beyond
    Wolfson, Noah A.
    Ann Pitcairn, Carol
    Fierke, Carol A.
    BIOPOLYMERS, 2013, 99 (02) : 112 - 126
  • [48] Docking of Hydroxamic Acids into HDAC1 and HDAC8: A Rationalization of Activity Trends and Selectivities
    Ortore, Gabriella
    Di Colo, Francesco
    Martinelli, Adriano
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2009, 49 (12) : 2774 - 2785
  • [49] Crucial Structural Understanding for Selective HDAC8 Inhibition: Common Pharmacophores, Molecular Docking, Molecular Dynamics, and Zinc Binder Analysis of Selective HDAC8 inhibitors
    Sarkar, Kakali
    Debnath, Sudhan
    Sen, Debanjan
    Kar, Supratik
    Sil, Samir Kumar
    MEDICINAL CHEMISTRY, 2024,
  • [50] Exploration of histone deacetylase 8 inhibitors through classification QSAR study: Part II
    Amin, Sk Abdul
    Adhikari, Nilanjan
    Jha, Tarun
    JOURNAL OF MOLECULAR STRUCTURE, 2020, 1204